Immunomedics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.34%57.950.0%$1725.05m
GILDGilead Sciences, Inc. -0.43%75.001.0%$1312.82m
REGNRegeneron Pharmaceuticals, Inc. 0.64%581.942.5%$967.55m
AMGNAmgen, Inc. -0.13%223.851.3%$645.53m
NVAXNovavax, Inc. -0.62%44.56102.0%$576.10m
VRTXVertex Pharmaceuticals, Inc. 0.20%277.931.9%$545.78m
BIIBBiogen, Inc. 0.37%301.601.6%$411.90m
ILMNIllumina, Inc. -1.88%366.013.5%$381.88m
SRNESorrento Therapeutics, Inc. -0.29%4.941.8%$297.10m
ALXNAlexion Pharmaceuticals, Inc. 1.59%116.242.0%$269.28m
SGENSeattle Genetics, Inc. -0.23%151.206.1%$253.91m
AAgilent Technologies, Inc. 0.35%86.991.6%$200.20m
BMRNBioMarin Pharmaceutical, Inc. -1.48%104.044.3%$177.12m
CODXCo-Diagnostics, Inc. -1.03%17.290.0%$169.10m
INCYIncyte Corp. -0.66%99.892.5%$156.46m

Company Profile

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.